Market Overview

Benzinga's Top Upgrades, Downgrades For December 12, 2018

Share:

Top Upgrades

  • Citigroup upgraded Lululemon Athletica inc. (NASDAQ: LULU) from Neutral to Buy. Lululemon shares rose 2.5 percent to $119.80 in pre-market trading.
  • Cantor Fitzgerald upgraded Corcept Therapeutics Incorporated (NASDAQ: CORT) from Neutral to Overweight. Corcept Therapeutics shares rose 5.2 percent to $18.06 in pre-market trading.
  • Citigroup upgraded Realty Income Corp (NYSE: O) from Sell to Neutral. Realty Income shares rose 0.97 percent to close at $66.30 on Tuesday.

 

Top Downgrades

  • Morgan Stanley downgraded eBay Inc (NASDAQ: EBAY) from Overweight to Equal-Weight. eBay shares fell 1.3 percent to $28.67 in pre-market trading.
  • Citigroup downgraded Marriott International Inc (NASDAQ: MAR) from Buy to Neutral. Marriott shares rose 0.6 percent to $110.72 in pre-market trading.
  • JP Morgan downgraded Mosaic Co (NYSE: MOS) from Overweight to Neutral. Mosaic shares fell 0.6 percent to close at $33.00 on Tuesday.
  • Keefe Bruyette & Woods downgraded Bank of America Corp (NYSE: BAC) from Outperform to Market Perform. Bank of America shares rose 1.1 percent to $24.84 in pre-market trading.
  • Morgan Stanley downgraded Verizon Communications Inc. (NYSE: VZ) from Overweight to Equal-Weight. Verizon shares fell 1.8 percent to $57.80 in pre-market trading.
  • Citigroup downgraded Hyatt Hotels Corporation (NYSE: H) from Buy to Neutral. Hyatt shares rose 1 percent to $68.10 in pre-market trading.
  • JP Morgan downgraded Waters Corporation (NYSE: WAT) from Neutral to Underweight. Waters shares rose 0.4 percent to $190.59 in pre-market trading.

 

Top Initiations

  • Analysts at Oppenheimer initiated coverage on GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) with a Perform rating. The price target for GW Pharmaceuticals is set to $142. GW Pharmaceuticals shares closed at $122.99 on Tuesday.
  • Bank of America initiated coverage on Foamix Pharmaceuticals Ltd (NASDAQ: FOMX) with a Buy rating. The price target for Foamix Pharmaceuticals is set to $11. Foamix Pharmaceuticals shares closed at $3.81 on Tuesday.
  • B. Riley FBR initiated coverage on Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) with a Neutral rating. The price target for Madrigal Pharmaceuticals is set to $124. Madrigal Pharmaceuticals shares closed at $114.63 on Tuesday.
  • Oppenheimer initiated coverage on Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) with an Outperform rating. The price target for Jazz Pharmaceuticals is set to $180. Jazz Pharmaceuticals shares closed at $140.38 on Tuesday.
  • B. Riley FBR initiated coverage on Intercept Pharmaceuticals Inc (NASDAQ: ICPT) with a Buy rating. The price target for Intercept Pharmaceuticals is set to $155. Intercept Pharmaceuticals shares closed at $104.59 on Tuesday.
  • Canaccord Genuity initiated coverage on BioScrip Inc (NASDAQ: BIOS) with a Buy rating. The price target for BioScrip is set to $5. BioScrip shares closed at $3.85 on Tuesday.
 

Related Articles (BIOS + BAC)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Pre-Market Outlook Analyst Ratings

Latest Ratings

StockFirmActionPT
INTUStifelMaintains425.0
AMBADeutsche BankMaintains100.0
YDeutsche BankMaintains825.0
ELDeutsche BankMaintains316.0
SQGoldman SachsMaintains246.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com